Identification of immune subtypes of Ph-neg B-ALL with ferroptosis related genes and the potential implementation of Sorafenib

BACKGROUND: The clinical outcome of Philadelphia chromosome-negative B cell acute lymphoblastic leukemia (Ph-neg B-ALL) varies considerably from one person to another after clinical treatment due to lack of targeted therapies and leukemia’s heterogeneity. Ferroptosis is a recently discovered program...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Yang, Zhang, Ling, Tian, Xiaopeng, Xiang, Xin, Yu, Yan, Zeng, Zhao, Cao, Yaqing, Chen, Suning, Sun, Aining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670244/
https://www.ncbi.nlm.nih.gov/pubmed/34906116
http://dx.doi.org/10.1186/s12885-021-09076-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670244/
https://www.ncbi.nlm.nih.gov/pubmed/34906116
http://dx.doi.org/10.1186/s12885-021-09076-w

Ejemplares similares